Intra-ethnic differences in genetic variants of the UGT-glucuronosyltransferase 1A1 gene in Chinese populations

Pharmacogenomics Journal

Volumn 7, Issue 5, 2007, Pages 333-338

  Zhang, A ^a,b   Xing, Q ^a,b   Qin, S ^a,b   Du, J ^a,b   Wang, L ^a,b   Yu, L ^a,b   Li, X ^a,b   Xu, L ^c   Xu, M ^d   Feng, G ^e   He, L ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c WANNAN MEDICAL COLLEGE   (China)

^d Anhui Institute of Parasitic Diseases   (China)

^e SHANGHAI MENTAL HEALTH CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; GLUCURONOSYLTRANSFERASE 1A1; IRINOTECAN;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CHINESE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE STRUCTURE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE MAP; HETEROZYGOTE; HUMAN; MALE; MOLECULAR EVOLUTION; NORMAL HUMAN; PHARMACOGENETICS; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNSPECIFIED SIDE EFFECT; WILD TYPE;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASIAN CONTINENTAL ANCESTRY GROUP; BILIRUBIN; BONE MARROW DISEASES; CAMPTOTHECIN; CHINA; ETHNIC GROUPS; EXONS; FEMALE; GASTROINTESTINAL DISEASES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUCURONOSYLTRANSFERASE; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERBILIRUBINEMIA; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; REFERENCE VALUES; TATA BOX;

EID: 34748857912     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500424     Document Type: Article

References (21)

1. Maruo Y, Iwai M, Mori A, Sato H, Takeuchi Y. Polymorphism of UDP-glucuronosyltransferase and drug metabolism. Cur Drug Metab 2005; 6: 91-99.
2. Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR et al. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: Correlation of genotype to phenotype. Hum Mutat 2000; 16: 297-306.
3. Jinno H, Tanaka-Kagawa T, Hanioka N, Saeki M, Ishida S, Nishimura T et al. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) an active metabolite of irinotecan (CPT-11) by human UGT1A1 variants G71R P229Q and Y486D. Drug Metab Dispos 2003; 31: 108-111.
4. Kaniwa N, Kurose K, Jinno H, Tanaka-Kagawa T, Saito Y, Saeki M et al. Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C>T (P229L) found in an African-American. Drug Metab Dispos 2005; 33: 458-465.
5. Innocenti F, Undevia SD, Iyer L, Chen PX, Das SM, Kocherginsky M et al. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol 2004; 22: 1382-1388.
6. Kitagawa C, Ando M, Ando Y, Sekido Y, Wakai K, Imaizumi K et al. Genetic polymorphism in the phenobarbital-responsive enhancer module of the UDP-glucuronosyltransferase 1A1 gene and irinotecan toxicity. Pharmacogenet Genom 2005; 15: 35-41.
7. Innocenti F, Iyer L, Ratain MJ. Pharmacogenetics: A tool for individualizing antineoplastic therapy. Clin Pharmacokinet 2000; 39: 315-325.
8. Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 1998; 95: 8170-8174.
9. Premawardhena A, Fisher CA, Liu YT, Verma IC, de Silva S, Arambepola M et al. The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): Hematologic and evolutionary implications. Blood Cells Mol Dis 2003; 31: 98-101.
10. Innocenti F, Liu W, Chen P, Desai AA, Das S, Ratain MJ. Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes. Pharmacogenet Genom 2005; 15: 295-301.
11. Saeki M, Saito Y, Jinno H, Tohkin M, Kurose K, Kaniwa N et al. Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing. Clin Chem 2003; 49: 1182-1185.
12. Yamamoto A, Nishio H, Waku S, Yokoyama N, Yonetani M, Uetani Y et al. Gly71Arg mutation of the bilirubin UDP-glucuronosyltransferase 1A1 gene is associated with neonatal hyperbilirubinemia in the Japanese population. Kobe J Me Sci 2002; 48: 73-77.
13. Sutomo R, Talib NA, Yusoff NM, Van Rostenberghe H, Sadewa AH, Sunarti Sofro AS et al. Screening for G71R mutation of the UGT1A1 gene in the Javanese-Indonesian and Malay-Malaysian populations. Pediatr Int 2004; 46: 565-569.
14. Ki CS, Lee KA, Lee SY, Kim HJ, Cho SS, Park JH et al. Haplotype structure of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and its relationship to serum total bilirubin concentration in a male Korean population. Clin Chem 2003; 49: 2078-2081.
15. Huang CS, Luo GA, Huang ML, Yu SC, Yang SS. Variations of the bilirubin uridine-diphosphoglucuronosyl transferase 1A1 gene in healthy Taiwanese. Pharmacogenetics 2000; 10: 539-544.
16. Iyer L, Hall D, Das S, Mortell MA, Ramirez J, Kim S et al. Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism. Clin Pharmacol Ther 1999; 65: 576-582.
17. Sai K, Saeki M, Saito Y, Ozawa S, Katori N, Jinno H et al. UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer. Clin Pharmacol Ther 2004; 75: 501-515.
18. Wasserman E, Myara A, Lokiec F, Goldwasser F, Trivin F, Mahjoubi M et al. Severe CPT-11 toxicity in patients with Gilbert's syndrome: Two case reports. Ann Oncol 1997; 8: 1049-1051.
19. Lampe JW, Bigler J, Horner NK, Potter JD. UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations. Pharmacogenetics 1999; 9: 341-349.
20. Stephens M, Smith NJ, Donnelly P. A new statisticalmethod for haplotype reconstruction from population data. Am J Hum Gene 2001; 68: 978-989.
21. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.